Cervical Cancer Awareness
January is National Cervical Cancer Awareness Month
Philadelphia, PA – One of the great success stories in cancer research, since annual Pap test cervical cancer screenings were introduced in the 1950s, cases of what was once the number one cancer in women have plummeted. Human Papillomavirus (HPV) vaccination has further reduced the numbers.
“Today, we know cervical cancer can be prevented with proper screening to find pre-cancers before they develop into invasive cancer,” says Paul Neumann, M.D., gynecologist, Chestnut Hill Hospital. “If a pre-cancer is found, it can be treated, stopping cervical cancer before it really starts.”
One factor in cervical cancer is the prevalence of the human papilloma virus (HPV) in society. An estimated 80% of sexually active women will become infected with the virus at some point, but of the more than 100 strains of HPV identified, only a few high-risk strains are connected to cervical cancer. The vast majority of HPV infections resolve without any treatment or intervention.
The Centers for Disease Control and Prevention recommends young women and men receive HPV vaccination at 11 or 12 years of age to provide the best protection long before the start of any sexual activity. Catch-up vaccines are recommended for males through age 21 and for females through 26 years of age. In females, vaccination helps protect against two types of HPV that cause 70 percent of cervical cancer cases.
“Unfortunately, the CDC reports more than 4,000 U.S. women still die from cervical cancer every year,” says Dr. Neumann. “Women at risk of dying from the disease today are those who have been screened infrequently – or not at all.”
Recently, changing guidelines about screening frequency have created confusion. What used to be a clear direction from the American Cancer Society – “get a yearly Pap test” – has become less clear. Recommended time between screenings is now longer, and two separate tests are available.
While not all physicians agree on the new guidelines, following are good rules from the American Congress of Obstetricians and Gynecologists and the American Cancer Society to protect yourself against cervical cancer. Be proactive in discussing with your doctor whether these screening guidelines are right for you.
- All women should begin cervical cancer screening via a Pap test at age 21.
- Women between the ages of 21 and 29 should have a Pap test at least every three years. HPV testing should be done only if needed after an abnormal Pap test.
- Women between the ages of 30 and 65 should have both a Pap test and an HPV test at least every five years.
- Women over 65 who have had regular screenings with normal results should not be screened for cervical cancer.
- Women who are at increased risk for cervical cancer may need to increase the frequency of these screenings. Notably, African American and Hispanic women have a higher incidence of cervical cancer than other ethnic groups.
In short, the American Cancer Society no longer recommends getting a Pap test every year, because it generally takes longer than that (10-20 years) for cervical cancer to develop. As the debate continues, there is also the option to have a separate test for HPV alone. Again, discuss with your doctor the appropriate actions based on your age, lifestyle and risk factors.
To find a physician or learn more about taking care of your health, visit the Find A Doctor section of this site or call (215) 753-2000.
Chestnut Hill Hospital (CHH) is a community-based, university-affiliated, teaching hospital committed to excellent patient-centered care. CHH provides a full range of inpatient and outpatient, diagnostic and treatment services for our neighbors in northwest Philadelphia and eastern Montgomery County. More than 300 board-certified physicians comprise the medical staff and support medical specialties including minimally invasive laparoscopic and robotic surgery, cardiology, gynecology, oncology, orthopedics, urology, family practice and internal medicine. Our comprehensive services include primary care practices, two women’s centers and an off-site physical therapy center. CHH is affiliated with university-hospitals in Philadelphia for heart and stroke care, as well as our hospitalist and residency programs. Chestnut Hill has 130-beds and is accredited by the Joint Commission.